Hjem › Relaps-remitterende multipel sklerose › Texas
Relaps-remitterende multipel sklerose kliniske forsøg i Texas
4 studier for Relaps-remitterende multipel sklerose søger deltagere på steder i Texas.
Officiel studietekst (engelsk)
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- University of Texas Southwestern Medical Center: Division of Multiple Sclerosis and Neuroimmunology, Dallas
- Maxine Mesigner Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine Medical Center, Houston
RekruttererFase 3
Alder 18 til 55 · Alle køn · Opdateret 16. sep. 2026 · NCT04047628Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
- The University of Texas at Dallas, Richardson
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 15. sep. 2026 · NCT05958381Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0133, El Paso
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 10. sep. 2026 · NCT06408259The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
- The University of Texas at Austin, Austin
- The University of Texas Health Science Center at Houston, Houston
Rekrutterer
Alder 22 til 60 · Alle køn · Opdateret 2. sep. 2026 · NCT06796504Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.